The 50-Day Sprint

March 1st is here, which means 4/20, is exactly 50 days away. For US cannabis retailers, the quiet of this early March weekend is the calm before the storm. The next seven weeks will determine whether your store simply survives the holiday or maximizes its revenue potential.

4/20 isn’t just another holiday on the retail calendar—it’s the single biggest sales event of the year for U.S. cannabis operators. In 2025, retailers across the U.S. and Canada generated over $50 million in sales and moved more than 3 million units in a single day, underscoring the sheer scale of the opportunity ahead. The momentum has been building year over year: U.S. dispensaries recorded $181.4 million in 4/20 sales in 2024, exceeding 2023’s already massive totals. Many markets regularly see 2× to 2.7× their typical daily sales on 4/20, making the next 50 days crucial for any retailer looking to fully capitalize on the surge

Now is the time to shift from standard operations to holiday prep. What should operators be tackling this week?

1. Inventory Audits & Bulk Purchasing

Supply chains will tighten as April approaches. Start running velocity reports on your top-selling SKUs from the past 90 days and compare them to last year's 4/20 data. Begin negotiations with brands now for bulk discounts and secured allocations before the mid-March scramble.

2. Stress-Testing Tech Stacks

A crashed POS system or a glitchy online menu on April 20th is a catastrophic revenue leak. Use this week to stress-test your e-commerce integration. Ensure your inventory syncs perfectly between your vault and platforms like Weedmaps or Leafly. Check your hardware—are all barcode scanners and receipt printers functioning flawlessly?

3. Finalizing Marketing & Brand Partnerships

Brands are locking in their 4/20 budgets right now. Reach out to your top vendors to finalize in-store pop-ups, BOGO deals, and co-branded marketing pushes. Securing these partnerships early guarantees your dispensary gets prime promotional support before brand reps are booked solid.

4. Building the 4/20 Marketing Timeline (Start Now, Not April 15th)

4/20 marketing isn’t a one-week push. It’s a 50-day runway.

Map out a phased campaign:

• Tease phase (Days 50–30): Build anticipation. Drop “Save the Date” messaging. Start aggressively collecting emails and SMS opt-ins. Promote loyalty sign-ups with a clear 4/20 incentive.

• Reveal phase (Days 30–14): Announce select deals, brand partners and event elements. Spotlight one category per week (vapes, pre-rolls, edibles) to warm up demand.

• Conversion phase (Days 14–1): Push hard on preorder windows, bundle drops and limited allocations.

Retailers who wait until April to “start marketing” are just shouting into the noise. The stores that win 4/20 own the conversation in March.

5. Owning Digital Shelf Space Before the Surge

On 4/20, consumers don’t browse casually. They search, compare, and buy fast.

Now is the time to:

• Optimize your online menu descriptions and images for top SKUs.

• Lock in sponsored placements on Weedmaps and Leafly before inventory spikes.

• Refresh your Google Business profile with updated hours, event messaging, and clear calls to action.

• Audit your website speed. Slow load times on mobile during peak traffic cost revenue.

If your digital storefront feels cluttered or outdated, you’re leaking margin before the line even forms outside.

By acting proactively at the 50-day mark, retailers can transform the chaos of 4/20 into a streamlined, highly profitable operation.

The Roundup

Staffing Check-in: Begin forecasting your labor needs for the week of 4/20. Start conversations with your top budtenders about blackout dates and incentivize weekend shifts to prevent burnout before the rush.

Compliance Reminder: High volume increases the risk of compliance slip-ups. Schedule a brief all-hands refresher on ID checking and daily purchasing limits to ensure your team stays sharp.

The retail cannabis landscape is undergoing a tectonic shift as mainstream giants enter the space through the hemp-derived THC loophole. In Minnesota, Target has begun a pilot program selling THC-infused beverages in select locations. Early consumer data suggests a strong positive reaction, with a new poll indicating that over half of cannabis consumers are more likely to shop at Target following this decision. This move normalizes cannabis consumption for the mass market and introduces formidable competition for traditional dispensaries.

Simultaneously, licensed multi-state operators are fighting back against the encroachment of intoxicating hemp products. Jushi Holdings, through a subsidiary, has launched a sweeping lawsuit in Virginia against DoorDash, Total Wine, and other retailers. The suit alleges these companies are illegally selling intoxicating hemp products that exceed state THC limits, undermining the heavily regulated and taxed medical marijuana market. This legal clash highlights the growing tension between the established, state-licensed cannabis industry and the lightly regulated, rapidly expanding hemp-derived consumable market.

Regulatory Update

• Virginia Pushes Toward Adult-Use Sales: A House committee has advanced a revised bill to legalize recreational marijuana sales, setting the stage for bicameral negotiations. The current proposal would limit existing medical operators to indoor cultivation and allow microbusinesses up to two locations. [Read More]

• South Dakota Streamlines Medical Oversight: The state House passed a bill to eliminate the Medical Marijuana Oversight Committee, citing it as an unnecessary layer of bureaucracy. If approved by the Senate, the Department of Health will oversee the program solely. [Read More]

Industry Moves

• Ohio Crosses the $1B Mark: In its first full year of legal sales, Ohio dispensaries sold over $1 billion worth of cannabis ($836M recreational, $233M medical). However, the market faces new restrictions under a recently signed law that lowers THC caps and removes certain employment protections. [Read More]

• Michigan Sales Plunge: Warning signs are emerging in mature markets, as Michigan reported a sharp 15.9% sequential drop in January cannabis sales. Adult-use flower prices also fell 11.2% year-over-year to $945 per pound, indicating significant price compression. [Read More]

• Florida Advances Veteran Fee Reductions: Florida lawmakers are moving forward with a bill to slash the medical marijuana registry identification card fee for military veterans from $75 down to $15, potentially boosting patient enrollment. [Read More]

Trend Watch

• The Mainstreaming of THC Beverages: Target's soft launch of THC drinks is a major indicator that big-box retail is ready to capitalize on the cannabis beverage sector, bypassing the traditional dispensary model. [Read More]

• MSOs vs. Mainstream Delivery: The lawsuit by Jushi against DoorDash and Total Wine marks a critical escalation as licensed cannabis retailers attempt to use the courts to stifle competition from mainstream entities selling hemp-derived intoxicants. [Read More]

In an increasingly saturated cannabis market, product differentiation can only get you so far. When multiple dispensaries within a five-mile radius carry the exact same brands and strains, why should a customer choose yours?

The answer isn't always pricing or interior design.
It's the people behind the counter.

Treating budtenders as mere cashiers is one of the most expensive mistakes a cannabis retailer can make. When optimized correctly, your frontline staff aren't just ringing up sales—they are your primary drivers for increased basket sizes, customer retention, and brand loyalty.

Here is how top-performing retailers are optimizing their operations through strategic budtender training:

1. Shift from 'Clerks' to 'Consultants'

Customers, especially newer demographics entering the market, are often overwhelmed by the sheer volume of choices—terpenes, cannabinoids, consumption methods, and dosages. A highly trained budtender acts as a cannabis sommelier. By asking the right questions ('What kind of experience are you looking for?' rather than 'What do you want?'), they build trust. Trust directly correlates to a willingness to try premium, higher-margin products.

2. The Power of the Add-On (Without Being Pushy)

Effective retail optimization relies heavily on increasing the Average Order Value (AOV). Training staff on natural pairing techniques (e.g., suggesting a pack of low-dose edibles to go with a premium flower purchase for sustained effects) can boost daily revenue by 15-20% without increasing foot traffic. This requires deep product knowledge and an understanding of consumer habits, which only comes from consistent, structured training.

3. Standardizing the Education Loop

Vendor pop-ups are great, but they shouldn't be your only source of staff education. Develop an internal 'knowledge base' and hold weekly 15-minute briefings on new products, changing regulations, and customer feedback trends. When the whole team has a unified understanding of the inventory, the customer experience becomes consistently excellent, regardless of who is working the register.

4. Combating Turnover Through Investment

The retail cannabis sector struggles with high turnover rates. Investing in your employees' professional development signals that they have a career path, not just a gig. Comprehensive training programs reduce burnout, build confidence, and ultimately save operators thousands of dollars in constant hiring and onboarding costs.

The Bottom Line

Retail optimization isn't just about software and store layout. Your highest ROI will always come from the human element. Equip your budtenders with the knowledge to lead the customer journey, and the margins will follow.

The cannabis industry entered 2026 with something it hasn't had in years: momentum. Fueled by President Trump's December 18, 2025 executive order to reschedule marijuana from Schedule I to Schedule III, a flurry of acquisitions, debt restructurings, and strategic pivots are reshaping the competitive landscape — and we're not even out of Q1.

Wyld Swallows Grön in a Big Edibles Play

The most talked-about brand deal of early 2026 is Oregon-based Wyld's acquisition of fellow Oregonian edibles maker Grön. The move brings together two of the most recognized names in the $4.8 billion cannabis edibles category. Combined, the companies now employ roughly 1,400 people and reach approximately 12,000 retail locations across the U.S. and Canada. Wyld, already available in 16 states, gains Grön's 75-product lineup and nine-state footprint. Grön, for its part, gains the resources and distribution muscle to scale nationally. The deal positions the combined entity as arguably the most dominant force in cannabis edibles today.

Millstreet Moves on Cannabist Virginia — And Changes the Game

In a deal that sent shockwaves through the industry, Millstreet Credit Fund acquired Cannabist's Virginia cannabis assets for $130 million in a loan-to-own transaction. What makes this significant isn't just the price tag — it's who's buying. Millstreet is a credit fund, not a traditional multi-state operator (MSO). The message? Lenders are now competing directly with cannabis companies for prime assets, signaling that debt — not equity — may drive the next wave of industry consolidation.

Ayr Wellness Loses Ground in Multiple States

Not every story in early 2026 is one of strength. Ayr Wellness has had a rough start to the year, losing assets to foreclosure in both New Jersey and Ohio. The company's shrinking footprint serves as a cautionary tale about overleveraged cannabis businesses facing debt maturities with no clear exit. More state-level asset transfers from Ayr are expected as regulatory approvals move forward.

Green Thumb and Curaleaf Double Down on Capital

Two of the industry's biggest MSOs made major financial moves in February. Green Thumb Industries secured an additional $50 million in senior debt financing, while Curaleaf closed a $500 million private placement of 11.5% senior secured notes due 2029. Both moves signal confidence in the long-term direction of federal policy — and a desire to be well-capitalized when rescheduling is fully finalized.

Planet 13 Exits California

In a sign of the times for the Golden State, Planet 13 completed its exit from California, selling its assets to Catalyst Cannabis. With wholesale prices in some markets down as much as 67% from their peak, it's becoming increasingly difficult for large publicly traded MSOs to compete against leaner, lower-cost local operators. California isn't going away — but it's increasingly a market for scrappy independents, not big brands burning overhead.

What's Driving All of This?

The short answer: debt, rescheduling optimism, and survival instincts. Companies with clean balance sheets are snapping up distressed assets at compressed valuations. Lenders are converting debt to ownership. And brands that built market dominance — like Wyld — are using this window to lock in long-term category leadership before the next wave of national competition arrives.

The big wildcard remains Section 280E. If rescheduling is finalized, cannabis companies will finally be able to deduct standard business expenses — a change that could slash effective tax rates from 70%+ down to normal business levels. That single shift could unlock billions in capital and trigger a deal wave that makes early 2026 look like a warm-up.

If you run an independent store (or a small chain), your store manager needs a weekly scorecard that’s small enough to use—and sharp enough to expose problems early.

Below is the scorecard we’d use if we had to walk into a store cold and figure out, in 15 minutes, whether it’s being run well.

THE RULE (BEFORE THE METRICS)

• Weekly cadence, same day/time, same format. Monday morning is ideal.

• Trends > trivia. The goal isn’t a perfect number; it’s seeing direction and catching breakpoints.

• Every metric needs an owner + a “so what.” If a number moves, the manager must say what changed and what they’re doing next.

1) SALES HEALTH (are we growing—or just busy?)

Have your manager report:

• Total weekly sales (vs prior week + vs same week last year if you have it)

• Transactions (count)

• Average basket size (sales ÷ transactions)

• Discount rate (discounts ÷ gross sales), if you track it

What you’re looking for:

• Sales up but basket down = you’re buying traffic with promos.

• Transactions flat but sales up = merchandising or pricing is doing work (good—verify margin).

2) MARGIN REALITY (are we making money on what we sell?)

Have your manager report:

• Gross margin % (weekly)

• Top 10 SKUs by revenue + top 10 by gross profit dollars

• Category margin callouts (any category that is dragging margin)

What you’re looking for:

• Best-sellers that don’t make money. If it’s in the top 10 revenue but not top profit, it needs attention (pricing, promos, vendor terms, or swap).

3) LABOR CONTROL (is payroll aligned with demand?)

Have your manager report:

• Labor % of sales (weekly payroll ÷ sales)

• Hours scheduled vs hours worked (were we disciplined or chaotic?)

• Sales per labor hour (simple productivity signal)

What you’re looking for:

• Overtime and “we were slammed” stories that repeat every week = scheduling failure, not a surprise.

4) INVENTORY DISCIPLINE (is cash trapped on the shelf?)

Have your manager report:

• Inventory on hand ($ at cost) and weeks of supply (rough is fine)

• # of SKUs carried (total)

• Top dead stock list: 10 SKUs with the oldest units / slowest movement

• Stockouts that mattered (missed sales you can name)

What you’re looking for:

• Too many SKUs + slow movers = margin and cash flow leak.

• Frequent stockouts on core items = bad reorder points or vendor reliability issues.

5) COMPLIANCE + SHRINK (are we leaking product, money, or risk?)

Have your manager report:

• Inventory adjustments (count + reason codes)

• Void/refund counts (and top reasons)

• Any compliance incidents (ID failures, labeling holds, METRC/BioTrack issues, etc.)

• Camera/audit exceptions (if you track them)

What you’re looking for:

• “Misc adjustments” is not an answer. Shrink must have categories and follow-up.

6) CUSTOMER SIGNALS (are we earning repeat business?)

Have your manager report:

• Loyalty sign-ups (weekly) and loyalty redemption rate (if available)

• Return customer % (if POS supports it)

• Top 3 customer complaints (pattern-based, not one-offs)

What you’re looking for:

• Complaints that map to operations: wait times, product knowledge, wrong item, out-of-stocks.

WHAT THIS MEANS FOR OPERATORS

• If you implement only one thing this quarter: make your manager own this scorecard weekly.

• The scorecard is not for punishment—it’s for early detection. The best operators fix small issues before they become expensive ones.

• Keep it tight. If you add a metric, remove a metric. A bloated scorecard becomes theater.

Your store manager doesn’t need 50 KPIs. They need 12–20 numbers that force clarity. Run this weekly for a month and you’ll know exactly where the business is strong—and where it’s leaking.

Seven years ago, cannabis was the next great American growth industry. Get in early and watch your money multiply.

A $10,000 investment in the top 10 publicly traded cannabis companies at their early peaks would be worth $1,500 to $2,000 today. An 85 percent loss.

The Wipeout:

• Curaleaf (CURLF): C$11.45 → $2.70 (76% loss)

• Tilray (TLRY): $17 IPO → $300 peak → $8.09 today (97% from peak)

• Cronos Group (CRON): $23.70 → $2.69 (89% loss)

• Glass House, Verano, Cresco, Aurora: Down 70-90%
  

Yet well-run dispensaries in strong markets generate healthy profits. The question isn’t whether profitability is possible—it’s how to achieve it.

What the Numbers Show

A GreenBooks CPA analysis of New York dispensaries reveals the divide between market perception and operational reality in this tale of two cities:

Manhattan Dispensary

200 to 400 customers per day at an average of $60 per customer = $4.4 million to $8.8 million annually.

Set up costs $380,000-$800,000, including.

• Leases: $80-$150/sq ft annually

• Renovations: up to $500,000

• Initial inventory: $100,000-$150,000

• Store managers: $60,000-$80,000

• Budtenders: $35,000-$45,000

• Utilities: $5,000-$10,000/month

Buffalo Dispensary

100 to 200 customers per day at an average of $50 per customer = $1.8 million to $3.7 million annually.

Leaner economics as you can see:

• Leases: $20-$40/sq ft annually

• Renovations: $100,000-$300,000

• Store managers: $50,000-$65,000

• Budtenders: $30,000-$40,000

• Monthly overhead: $3,000-$7,000

Manageable numbers in most retail sectors. Cannabis is different.

The 280E Tax Trap

IRS Code Section 280E prohibits cannabis businesses from deducting ordinary expenses because marijuana remains Schedule I federally. Dispensaries face 70 to 90 percent effective tax rates—triple comparable retail.

“A dispensary in Manhattan, generating $5 million in annual revenue, might face a federal tax liability upwards of $3.5 million due to 280E limitations,” the GreenBooks analysis states.

This explains why public companies generate revenue growth while destroying shareholder value. Federal tax policy makes profitability elusive at scale.
The only relief: Cost of Goods Sold deductions. This spawned specialized cannabis accounting focused on maximizing COGS categorization.

Why Public Cannabis Companies Failed

Curaleaf, Trulieve, and peers raced to build multi-state empires through acquisitions funded by capital raises dependent on rising stock prices. When prices collapsed, high debt and bloated structures became anchors.

Focused regional operators with vertically integrated operations, optimizing COGS, found viable paths to profitability. The difference: controlled expansion, lean operations, and a focus on unit economics.

Lessons for Retail Operators

Location drives everything. Manhattan’s $8.8 million potential versus Buffalo’s $3.7 million creates operational leverage that absorbs fixed costs and funds customer experience.

Tax optimization determines profitability. Specialized CPAs who understand COGS maximization make the difference through accurate cost categorization, efficient inventory management, and strategic structuring.

Lean beats empire building. Multi-state operator wreckage proves growth without discipline destroys value. Better to dominate one market with excellent unit economics.
Diversify revenue streams. Non-cannabis products may be taxed differently. Merchandise, consulting, or ancillary offerings provide income not subject to 280E.
Patient capital wins. The rush to go public pushed unsustainable growth. Private operators with realistic timelines build profitable businesses generating consistent returns.

The Rescheduling Question

Trump signed the executive order on December 18, outlining a path that could address 280 (e). Federal rescheduling from Schedule I to Schedule III could transform economics overnight. A Manhattan dispensary paying $3.5 million in taxes might see that drop to $1 million, converting losses to profits.

But operators can’t wait. The industry’s history of “imminent” legalization promises dating to 2018 counsels skepticism. Build businesses that work under current rules.

The Bottom Line

The public market collapse signals the end of growth-at-any-cost. Dispensaries in strong markets with disciplined operations, optimized tax strategies, and lean structures generate healthy profits.

Seven years in, the truth: profitability isn’t about riding legalization waves or exchange listings. It’s about retail fundamentals—location, operations, margin management—executed with precision.

For professionals who master these basics, the opportunity remains substantial. Consolidation removes overcapitalized competitors, leaving room for operators who understand profit comes from doing the basics exceptionally well.

The headlines made it sound decisive: cannabis is being reclassified to Schedule III. But across the most credible reporting and legal analysis, one conclusion stands out clearly that most of us in cannabis know … rescheduling is real momentum, not instant relief.

What happens next depends less on politics and more on process.

What the executive order actually does — and doesn’t do

In its reporting on President Trump’s executive order, NPR emphasized that reclassification is meant to “facilitate medical research” and modernize how the federal government treats cannabis scientifically, not to legalize it outright or override state law. That distinction matters. The order signals intent, but implementation still runs through federal agencies, rulemaking and timelines that extend well beyond the announcement itself.

The most grounded state-level reporting

Among the clearest-eyed coverage comes from Bridge Michigan, which framed rescheduling as a meaningful shift — but one that arrives slowly and unevenly.

The outlet reported that the change would not take effect until at least the second quarter of the following year and would not legalize recreational cannabis nationwide. That nuance cuts through the noise and sets realistic expectations for operators.

Jerry Millen, owner of Greenhouse Dispensary in Walled Lake, told Bridge Michigan that the biggest immediate impact may not be financial at all. “As soon as it goes into place, you’re going to start to see more studies,” Millen said, adding that broader research could further shift public and institutional attitudes toward cannabis.

280E is the economic center of gravity

If there is one reason Schedule III has captured industry attention, it’s federal tax code Section 280E.

Bridge Michigan also quoted Ross Sloan, cannabis banking officer at Dart Bank, explaining that cannabis businesses are currently taxed on gross profit rather than net income — a structural disadvantage that Schedule III could eliminate. That single change would materially alter cash flow, margins and long-term valuation models across the industry.

Legal experts urge caution, not celebration

On the legal side, Harris Sliwoski offered one of the most practical analyses of what rescheduling would and would not change.

Attorney Vince Sliwoski wrote that removing cannabis from Schedule I would indeed neutralize 280E at the federal level — a development he described as potentially transformative. But he warned that states are under no obligation to follow suit. In fact, he noted that states could respond by increasing their own cannabis taxes once federal pressure eases.

That warning echoes concerns raised in Phoenix New Times, which highlighted how deeply dependent state and local governments have become on cannabis tax revenue. Any federal relief, the reporting suggests, may invite new political battles at the state level over who captures the financial upside.

Why “not happening soon” is still a credible take

While some coverage leans optimistic, Cannabis Business Times struck a more skeptical tone. In a sharply argued opinion piece, the publication emphasized that federal rescheduling is a multi-step administrative process — not a switch that flips overnight. Agencies move slowly, legal challenges are common and timelines often stretch far beyond early projections.
(Source: Cannabis Business Times)

That perspective doesn’t contradict the momentum; it contextualizes it.

Where aggressive tax strategies fit — briefly

Some tax professionals argue that 280E no longer applies based on federal health agency findings, a position covered by Outlaw Report. However, even that reporting acknowledges these approaches are being tested, not settled law.

For most operators, these strategies remain high-risk, highly specific and advisor-dependent, not industry-wide guidance.

The real takeaway for cannabis professionals

Taken together, the most credible reporting points to a single conclusion:

Schedule III is a structural shift, not a bailout.

It improves the research environment, opens the door to tax reform and reshapes long-term economics — but it does not eliminate federal illegality, guarantee state cooperation or remove regulatory complexity.

Operators who win in this next phase will be the ones who plan for change without assuming certainty, model upside without counting it early and treat rescheduling as the beginning of a new compliance era — not the end of the old one.

Cannabis beverages occupy a modest share of dispensary sales, but they have earned a durable place in the retail mix. In mature adult-use markets, beverages typically account for 2–4% of total store revenue, a figure that has remained remarkably steady over time. That consistency—more than headline growth—helps explain why retailers continue to refine the category rather than abandon it.

The story of cannabis beverages at retail is not one of rapid expansion. It is a story of predictability.

How the Category Behaves

Sales data and in-store experience point to a few clear patterns. Most beverage volume is concentrated in low-dose products, generally five milligrams of THC or less per container. These SKUs account for the bulk of unit sales and tend to generate fewer post-purchase issues than higher-dose edible formats.

Beverage buyers also skew toward repeat purchasing. Once customers find a product that fits their expectations, they tend to rebuy the same SKU rather than explore broadly. That dynamic rewards brands that deliver consistency and penalizes those that rely on novelty.

Price sensitivity is another defining characteristic. Compared with gummies or chocolates, beverages see sharper drop-offs in velocity as prices rise. Retailers reporting the strongest performance typically price beverages for multi-unit purchases and avoid positioning them as premium novelties.

Merchandising plays a meaningful role as well. Cold placement reliably improves sell-through, particularly for first-time buyers. Refrigeration does more than preserve product quality; it signals immediacy and use case in a way shelf placement does not.

Taken together, these behaviors explain why beverages have become a stable, if unspectacular, category. They do not spike. They do not disappear. They quietly do their job.

The Brands That Anchor the Set

Within those constraints, a small group of brands has emerged as consistent performers—products customers ask for by name and retailers reorder without hesitation.

Keef Brands

Keef remains the most widely recognized THC beverage brand in U.S. dispensaries. Its soda-style flavors, clear dosing, and predictable effects make it an anchor SKU for many stores. In practice, Keef often serves as the reference point against which other beverages are judged.

Cann

Cann leads the low-dose segment, particularly among consumers who prioritize control and repeatability. With two milligrams of THC per can, it has become a reliable entry point for customers who might otherwise skip the beverage category altogether.

Wynk

Wynk’s balanced THC/CBD formulations have found traction in both adult-use and medical settings. The appeal is straightforward: manageable effects and fewer surprises. For retailers, that translates into lower complaint rates and easier recommendations.

Artet

Artet occupies a narrower lane. It performs best in higher-income markets and curated dispensaries where premium beverages are merchandised intentionally. Where the demographic fits, customer loyalty is strong.

Nowadays

Nowadays behaves more like a bottle than a grab-and-go can. Positioned as an alcohol alternative, it sells as a planned purchase rather than an impulse item, with repeat buyers driving most of its volume.

Curaleaf (Select Beverages)

Select’s beverage line benefits from Curaleaf’s scale and operational consistency. While not the most differentiated offering, it remains a dependable option, particularly in medical dispensaries where availability and predictability matter most.

A Category Defined by Reliability

Cannabis beverages have not transformed dispensary economics, and they likely will not. What they have done is carve out a reliable role—one defined by repeat customers, low operational friction, and steady turnover.

For retailers, the takeaway is straightforward. Beverages earn their shelf space not through hype or innovation cycles, but through consistency. The brands that last are the ones customers rebuy, staff can explain quickly, and managers do not have to manage around. In a volatile industry, that kind of reliability is its own form of leadership.

The American cannabis market has reached an inflection point. 14 states permit lounges at various levels of implementation. Massachusetts approved regulations in December 2025 that create a new social-consumption market where adults can legally consume cannabis outside private homes for the first time.

The trend reflects a pragmatic consensus: states are moving toward regulated public consumption rather than leaving the market to chance. Unlike the haphazard early years of cannabis legalization, the lounge model comes with rigorous compliance requirements and local gatekeeping.

The States Moving Forward

Massachusetts: Three Models
Massachusetts regulators approved three license types: a Supplemental license for existing cannabis retailers to add on-site consumption; a Hospitality license for new or non-cannabis businesses to operate lounges in partnership with retailers; and an Event Organizer license for temporary consumption events.

The state imposed strict operational requirements. Lounges must offer rideshare and food service. Critically, municipalities retain opt-in authority through zoning changes or referendums. Timeline: 18 months estimated.

California: Expanding the Model
AB 1775 now allows licensed retailers to serve non-cannabis food and beverages and host live music events in consumption areas. The change was designed to improve unit economics for existing operators. Dozen lounges in California are concentrated in San Francisco and Oakland, with projections of 20 to 30 locations statewide.

Nevada: Tourist-Focused Regulation
Nevada has two types: Retail Lounges attached to existing dispensaries and standalone Independent Lounges designed to operate without serving alcohol. The state implemented strict operational controls, consumers capped at 50mg per session and requiring dedicated HVAC systems for smoking and vaping rooms. Odor undetectable outside premises is mandatory.

New Jersey: Boutique Approach
Only Class 5 eligible for consumption area endorsements. The application fee is $200 and the endorsement fee is $800, with annual operating fees of $5,000. Applications began January 2025, requiring municipal approval, Host Community Agreements, and detailed floor plans.

New York: Early Stages
Limited trial licenses granted as New York is in early phases. The state's Cannabis Law prohibits vertical integration—lounge licensees cannot hold dispensary, cultivation, or processor licenses. Two-year minimum lease required.

The Broader Picture

Early adopters: three states. Others—including the District of Columbia, Illinois, Maryland, Michigan, Minnesota, Missouri, and New Mexico—operate local opt-in models or restrict lounges to medical patients.

What distinguishes the current wave is the emphasis on local control. Rather than imposing a top-down mandate, states have crafted frameworks that grant municipalities discretion over whether to permit lounges at all. This reflects a deliberate choice: let communities decide what fits their needs.

Regulatory Framework

Consumption lounges face significant operational requirements, including separating consumption and retail areas, implementing advanced ventilation, enforcing age verification, maintaining security with video surveillance, and precise inventory tracking. Operators need retail licenses and local approval. These measures protect public health, safeguard operators' interests, and provide data for state evaluation.

What's Next

Pending bills in new states would legalize consumption lounges, suggesting the trend toward regulated public consumption will continue. How those states structure their frameworks will determine whether the model scales or remains a niche in high-tax, high-regulation jurisdictions like California and Massachusetts.

When Trump signed that executive order on December 18, my team was watching the market ticker in real time. Stock prices jumped. Then they cratered. The whiplash tells you everything about where we actually stand.

Look, rescheduling from Schedule I to Schedule III is real. It matters. But it's not the silver bullet anyone's pretending it is.

The Tax Thing Everyone Talks About

Here's the actual relief: Section 280E. This IRS rule has been killing us for years. It says cannabis businesses can't deduct normal operating expenses—rent, payroll, utilities—because marijuana's technically a Schedule I drug. Meaning we pay taxes on gross revenue while regular businesses pay on net profit. The math is brutal. A study by Whitney Economics found cannabis operators paid $2.3 billion in excess federal taxes in 2024 compared with ordinary businesses. Costar

Once we're Schedule III? That goes away.

Kim Rivers, Trulieve's CEO, said the order "acknowledges the medical benefits of cannabis, supports licensed and regulated operators, and allows law enforcement agencies to prosecute bad actors." PR Newswire She's right on the enforcement piece—this isn't legalization. It's just moving us from the heroin category to the Tylenol-with-codeine category. Both are controlled substances. One just admits we have medical value.

The Banking Problem Nobody Solved

But here's what still isn't fixed: credit cards. Curaleaf said rescheduling "eliminates onerous tax penalties and creates opportunities for expanded investment into state programs that will create jobs and tax revenue for local communities." Costar Fine words. But financial institutions still won't touch us because federal liability concerns don't disappear overnight.

Friday's still the cash apocalypse at my stores. That's not changing next quarter.

The Research Play

The other big angle is research. Boris Jordan, founder of Curaleaf, pointed out that while everyone talks about Schedule III from a tax perspective, his company is already funding studies overseas and running clinical trials in the UK. MJBizDaily He's positioning for FDA-approved cannabis medicines. That's a different business than retail. That takes a decade and hundreds of millions in capital.

For operators like me running dispensaries? We get easier research access. That's useful. But most patients aren't waiting for FDA trials. They're buying flower at my store next Friday.

The Real Problem: Oversupply and Price Wars

What rescheduling doesn't fix is the market getting demolished by oversupply. Washington state cannabis retailers are offering discounts as high as 39% on flower. Arizona hit 37% in some months. MJBizDaily When margins compress that hard, no tax relief hits fast enough.

2025 was difficult for the entire sector. Higher costs with price compression in most markets created historic challenges for operators. Cannabis Business Times That's the real state of the industry. We're fighting each other on price while the tax code—finally—gets friendlier.

What I'm Actually Watching

The immediate wins: when the rescheduling officially happens (still unclear on timing), 280E relief comes into play. That's real money back in operations. Kim Rivers has been cultivating a close relationship with the Trump administration, specifically through a personal connection with Trump's chief of staff Susie Wiles, and told CNBC she's interpreting the White House's language as a signal that the administration intends to rein in a chaotic market rather than expand it unchecked. CNBC

For now, rescheduling is a validation. It says the federal government finally admits cannabis isn't heroin. That matters for optics, research, and eventually banking reform.

But for those of us running retail? We're still in a cash business competing on discounts in oversaturated markets. The executive order moved the ball forward. It just didn't move it far enough.

As the U.S. cannabis retail landscape continues to evolve, entrepreneurs have a growing number of viable business models to consider. For this article, I’m using California and New York as examples, which offer distinct regulatory and market environments. California, with its mature, oversaturated market, and New York, with its equity-first approach, are still in early rollout. Each model has specific capital requirements, regulatory challenges, and strategic pros and cons. Below is a breakdown of five major dispensary business models with estimated startup costs, key insights, and a summarized SWOT analysis.

Standalone Retail Dispensary

Overview: The most traditional model is an independently operated cannabis retail store that purchases wholesale products from licensed growers and manufacturers to sell to consumers.

Startup Costs:

• California: Approximately $80,000–$250,000+, depending on location and buildout needs (source)

• New York: Typically $500,000–$1 million+ due to high real estate and compliance costs (source)

SWOT Summary:

• Strengths: Streamlined operations; flexibility in sourcing products; strong potential for developing a unique in-store experience.

• Weaknesses: Vulnerable to wholesale price fluctuations; thin margins due to taxes and operating costs.

• Opportunities: First-mover advantage in emerging markets; potential to build brand loyalty and expand to multiple locations.

• Threats: High local competition, regulatory shifts, challenges from black market competitors.

Standalone Retail Dispensary Examples

• The Green Cross – San Francisco, CA
  Longstanding independent dispensary with strong local advocacy and consistent product selection.

• Empire Cannabis Club – New York, NY
  Operates under a unique membership model within New York's evolving legal framework.

Regulatory Note: New York’s two-tier system prohibits licensees from holding both retail and supply chain licenses. California allows greater flexibility in license combinations.

Franchise Dispensary

Overview: Entrepreneurs operate a cannabis store under an established brand, leveraging a franchisor’s systems, branding, and operational guidance. Common examples include Cookies and Eufloria.

Startup Costs:

• Franchise fee: ~$40,000+

• Total estimated investment: $200,000–$500,000+, depending on state and location (example)

SWOT Summary:

• Strengths: Quick market entry; built-in customer base; franchisor support for compliance and operations.

• Weaknesses: Legal grey areas due to federal illegality; ongoing royalty obligations.

• Opportunities: Expanding a recognized brand into new territories; access to bulk purchasing deals.

• Threats: Restrictions on control and ownership in states like NY; reputational risk if franchisor faces legal or PR issues.

Franchise Dispensary Examples

• Cookies – Nationwide
  Global cannabis and lifestyle brand offering franchise opportunities in legal markets.

• Unity Rd. – Nationwide
  A turnkey dispensary franchise designed to help entrepreneurs enter the cannabis space compliantly.

Regulatory Note: Franchising is more viable in California due to its permissive licensing structure. In New York, franchise agreements must avoid conveying “ownership” or “control,” which are tightly regulated under equity and tiered licensing rules.

Delivery-Only Dispensary

Overview: These retailers do not operate a public-facing storefront. Instead, they accept orders remotely and deliver products to consumers, often from a secure warehouse or depot.

Startup Costs:

• Initial investment estimated at $200,000+, factoring in vehicles, tech infrastructure, and compliance measures (source)

SWOT Summary:

• Strengths: Lower real estate and buildout costs; expanded service area; fits modern consumer preferences.

• Weaknesses: Complex logistics; driver and asset security risks; lack of in-store upsell opportunities.

• Opportunities: Market penetration into delivery-only zones; expansion through technology and customer convenience.

• Threats: Increased compliance requirements; competition from unlicensed delivery services.

Delivery-Only Dispensary Examples

• Eaze – California
  One of the first and largest licensed cannabis delivery platforms in California.

• Doobie – Multi-State
  Operates delivery services in several legal states with a focus on convenience and compliance.

Regulatory Note: Delivery is permitted in California even in cities that ban storefronts (DCC). New York authorizes retail delivery and plans to offer standalone delivery licenses under its adult-use framework.

Social Equity Dispensary

Overview: Designed for individuals disproportionately affected by prior cannabis prohibition laws. These programs offer benefits such as reduced fees, priority licensing, and state-sponsored support.

Startup Costs:

• Varies widely; NY has offered grants up to $300,000 (source), though total costs still often exceed $500,000

SWOT Summary:

• Strengths: License prioritization; community support; potential access to grants and real estate assistance.

• Weaknesses: Limited access to private capital; dependency on underfunded government programs.

• Opportunities: Strategic partnerships; competitive advantage in early licensing rounds.

• Threats: Regulatory delays; illicit market competition; pressure to perform under public scrutiny.

Social Equity Dispensary Examples

• Nug – Oakland, CA
  Participates in Oakland's social equity program by incubating equity licensees.

• Housing Works Cannabis Co. – New York, NY
  Non-profit adult-use dispensary operated by a long-established community health organization.

Regulatory Note: Over 50% of New York’s adult-use licenses have gone to equity applicants (OCM). California provides millions in equity funding to municipalities supporting equity licensees.

Vertically Integrated Dispensary

Overview: These businesses control cultivation, manufacturing, and retail, consolidating the supply chain under one roof. They are common among multi-state operators (MSOs) and in tightly regulated markets.

Startup Costs:

• Full-scale vertical operations often require $1 million to $5 million+ (source).

SWOT Summary:

• Strengths: Maximized margins; supply chain control; brand consistency from seed to sale.

• Weaknesses: High barrier to entry; significant operational complexity.

• Opportunities: Product innovation; vertical brand scalability; potential tax advantages under 280E.

• Threats: Prohibition in some states like NY; risk concentration; regulatory oversight.

Vertically Integrated Dispensary Examples

• Curaleaf – Multi-State
  MSO with full control of cultivation, processing, and retail across multiple states.

• Ayr Wellness – Multi-State
  Vertically integrated operator offering in-house brands and products from seed to sale.

Regulatory Note: New York prohibits full vertical integration for most new licensees under the MRTA, except for legacy medical operators and microbusinesses. California allows full vertical integration and even offers a microbusiness license.

Final Thoughts

Each business model offers unique entry points into the cannabis industry depending on location, resources, and long-term goals. Entrepreneurs entering New York will benefit from equity-focused programs and early-mover status, while California operators must compete in a saturated and price-sensitive market. Successful cannabis retail ventures emphasize understanding local regulations, securing adequate funding, and delivering a strong brand experience.

If you’re thinking about jumping into the cannabis industry, or you’ve already been working in cannabis for years, you’ve probably been hearing the same buzz lately: federal legalization is right around the corner.

Yeah... about that.

The truth is more nuanced. Yes, real momentum is building (I know, you’ve heard that before). But if you’re banking your business plan (or your next expansion move) on sweeping federal reform happening in 2025, you’re setting yourself up for a rough ride. Here's the real scoop, what’s actually happening, where the real opportunities are, and what both newbies and seasoned pros should be doing right now.

Where Things Stand: Cannabis and the Feds

First, let’s be clear: cannabis is still classified as a Schedule I substance under the Controlled Substances Act. Same category as heroin.

But here’s where things are shifting:

• The DEA is moving to reschedule cannabis to Schedule III, following a formal recommendation by the U.S. Department of Health and Human Services.

• Schedule III would recognize medical use and significantly loosen tax restrictions (especially those brutal 280E rules), but still involve heavy regulation.

• Congress is circling cannabis banking reform again, with fresh momentum behind the SAFE Banking Act.

If rescheduling happens, and it’s looking more probable than possible, it would be the first major federal shift in cannabis policy in over 50 years.

But, and this is a big one: rescheduling is not legalization. It wouldn't automatically make cannabis legal for recreational use nationwide. It would mostly help with taxes, research, and possibly banking access.

What This Means for Newcomers

If you're thinking about entering cannabis right now, here’s the good news:

• More states are expanding access. Twenty-four states now allow adult-use cannabis as of 2025, with more eyeing ballot initiatives this year.

• Investor appetite is cautiously returning. Smart capital—from private equity to family offices—is starting to pick off distressed assets (Viridian Capital Advisors).

• Rescheduling would lower some major operational headaches, especially for businesses focused on medical cannabis.

But here's the reality check:

• You still need to operate state by state, with a messy patchwork of compliance rules.

• Big players are sharpening their knives for federal reform, meaning competition will be fierce when the walls come down.

• Banking and lending options remain limited, despite SAFE Banking chatter.

Bottom line: Enter with your eyes wide open, a compliance consultant on speed dial, and a seriously differentiated business model.

What This Means for Veterans

If you’ve been grinding through the messy gray zones for years, you already know how to pivot. But you need to be thinking about future-proofing your operation now, before federal reform reshapes the field.

Here’s how smart operators are moving:

• Cleaning up cap tables and financials to prep for mergers, acquisitions, or strategic investments.

• Strengthening brand identity, because when federal doors open, brands will matter even more.

• Exploring vertical integration carefully, but keeping flexibility in mind.

• Doubling down on compliance. States like New York are already enforcing cannabis regulations with federal-style intensity.

In short: Keep running your business like it already operates under federal scrutiny. Because one day soon, it just might.

Don’t Wait for D.C. to "Save" the Industry

If there’s one lesson cannabis entrepreneurs, new and veteran, have learned the hard way, it’s this: betting on politicians to fix your business model is a losing strategy.

The best-positioned companies are operating as if legalization is years away, not months. They’re getting profitable (or at least cash flow positive) at the state level. They’re finding niches. They’re focusing on execution, not hype.

Federal reform, when it comes, will reward businesses that are already running tight, compliant, consumer-driven operations, not those sitting on the sidelines waiting for a "green rush" 2.0.

Real talk: if you can't make it work now, legalization won’t save you. But if you can make it work today? You’ll be a monster tomorrow.

If you’re opening a dispensary in Connecticut, or anywhere, really, you’ll want to take a few notes from what just went down in New Britain, Connecticut.

420 Warehouse just opened its doors at 1 Hartford Square, and it’s already turning heads. Not because they threw a huge party (they did, with food trucks and games and a full mayoral blessing). What’s setting 420 Warehouse apart is something a lot more strategic: vertical integration, right from the jump.

What Makes 420 Warehouse Different

Unlike most Connecticut dispensaries, 420 Warehouse is located directly next to its own cultivation facility, Brix Cannabis. Having their grow operation and retail under one roof (well, technically two roofs) gives them serious advantages:

• Supply chain control: No scrambling for product from third-party growers.

• Consistency: Tighter control over quality, pricing, and inventory.

• Margins: Bigger cuts on every sale, since they’re cutting out the middleman.

In a market where dispensaries often struggle with slim margins and unpredictable supply, 420 Warehouse is setting itself up to win early and often.

They're also getting it right on the community engagement front. The dispensary is partnering with New Britain’s Training and Motivation Center to create workforce development programs for local youth, a smart way to build goodwill and strengthen local political capital, which will matter big-time when future licensing renewals and expansions come up.

Lessons for Cannabis Entrepreneurs

Vertical integration isn't a new idea, but it’s still rare, especially for small or mid-size operators. If you’re building a cannabis retail brand, the 420 Warehouse model shows a few things worth stealing:

• Co-location matters: Pairing cultivation and retail reduces friction. If zoning laws allow, consider this setup.

• Brand control: Owning your own grow means you control your brand experience from seed to sale (yes, really).

• Community roots: Smart operators know winning over the city council can be as important as winning over customers.

None of this happens without careful planning—and deep pockets—but it’s a model that's becoming harder to ignore as competition tightens.

Why Most Dispensaries Can't Just Copy This

Of course, setting up shop next to your grow isn't easy. Most municipalities have zoning laws tighter than a vault door when it comes to cultivation sites. Even in cannabis-friendly states, you’re likely to run into hurdles like:

• Zoning restrictions: Many cities separate grow facilities and retail zones by design.

• Licensing layers: Getting a cultivation license and a retail license often means navigating two completely separate bureaucracies.

• Capital intensity: Building and operating both a cultivation site and a dispensary can double or triple startup costs.

• Local politics: Some towns are fine with retail but dead-set against cultivation because of odor, security, or NIMBY complaints.

In Connecticut, especially, licensing is competitive and heavily regulated. Entrepreneurs who want to pull off what 420 Warehouse did will need serious compliance chops, an airtight real estate strategy, and let’s be honest, a bit of political finesse.

The Bottom Line

420 Warehouse isn’t just another ribbon-cutting. It’s a blueprint for what the next generation of dispensaries might look like: local, vertically integrated, and deeply rooted in the community. If you’re serious about building a defensible cannabis business, keep an eye on New Britain—and start thinking bigger than just a retail storefront.

If you’ve been running a dispensary anytime over the past five years, you already know: profit margins have been about as stable as a two-legged table.

Between 2020 and 2024, the dream of cannabis retail often crashed into the reality of oversaturated markets, nose-diving wholesale prices, relentless regulatory fees, and good old-fashioned supply-and-demand whiplash.

But 2025? It’s not the gold rush — and thank God for that. It’s the year of smarter, leaner, more resilient dispensary operations.

Let’s dig in.

Then: The Struggle Years (2020–2024)

Margins were brutal.
In peak 2022, average dispensary net margins hovered between 7% and 15%, depending on the market, according to Whitney Economics and Cannabiz Intelligence reports. In highly competitive states like California and Michigan, some operators reported barely breaking even, or worse, bleeding cash monthly just to survive.

Top-line revenue was misleading.
Sure, 2021 was a banner year for sales. But expenses skyrocketed just as fast. Between real estate, security, compliance, taxes, marketing, and shrinking wholesale prices, many shops that looked busy were still hanging by a thread.

New store openings fueled a vicious cycle.
For a while, the strategy was simple: open more stores, grab more market share, worry about profitability later. That worked — until it didn’t. By 2023, a Darwinian shakeout was in full force, with weaker players selling at pennies on the dollar or quietly folding.

Now: What’s Different in 2025

Operators finally learned to say no.
No to overpriced leases. No to carrying 500 SKUs they didn’t need. No to discounting themselves to death. 2025 dispensaries are tighter, savvier, and less desperate to chase every customer.

Smarter product curation = higher basket sizes.
Instead of acting like cannabis supermarkets, the best dispensaries are leaning into intentional merchandising, focusing on fewer, better products that move faster and drive higher margins. Data-backed SKU reduction is the name of the game.

Customer loyalty is actually…loyal now.
With fewer players in oversaturated markets, strong brands (and strong stores) are finally building real loyalty. Not just discounts. Not just points. Actual customer relationships.

Wholesale pricing has stabilized — a little.
In key mature markets, flower prices stopped free-falling for the first time in three years. It’s not a total recovery, but the bloodbath of $300 a pounds is finally giving way to a more sustainable wholesale environment.

New tech is helping.
Whether it’s AI-driven inventory management, dynamic pricing tools, or more innovative loyalty programs, technology is finally being used to boost margins instead of just looking good for investors.

The Numbers: 2025 vs. the Past

Here’s the rough comparison across legal states with mature markets:

(Sources: aggregated from Whitney Economics, Cannabiz Intelligence, and state regulatory reports)

Bottom Line: It’s a Real Business Now

2025 isn’t the year you get rich just because you opened a dispensary.

It’s the year you get rewarded for running a great business.

For the operators who tightened up, got disciplined, and treated cannabis retail like any serious business owner would, the future finally looks profitable again.

For everyone else? Well, there’s always the next hot market. Maybe.

Dispensaries across the U.S. once again proved that 4/20 is one of the cannabis industry's most powerful opportunities to drive sales, with 2025 bringing record-setting numbers.

According to data from Sweed, cannabis retailers saw an 81% increase in total products sold and a 65% jump in unique buyers compared to the previous year. Margins also improved notably, rising from 38.1% in 2024 to 50.4% in 2025.

Consumer behavior shifted slightly this year, with many choosing to shop earlier in the weekend. Saturday, April 19, outpaced Sunday in total revenue, driven by strategic promotions and early 4/20 celebrations.

In New Jersey, the momentum was undeniable. As reported by Heady NJ, dispensaries generated approximately $14.76 million in total sales over the 4/20 weekend. Friday, April 18, alone saw $5.25 million in sales—up sharply from about $9.8 million total during the 2024 4/20 weekend.

New York also showed impressive energy. According to StupidDope, dispensaries in Brooklyn and Manhattan saw long lines, heavy foot traffic, and midday sellouts of popular products — marking one of the state's strongest cannabis retail days since legalization.

A breakdown of product categories from Jane Technologies showed familiar favorites leading the way:

• Flower: 41%

• Vape Products: 27%

• Edibles: 14%

• Pre-rolls: 10%

• Extracts: 6%

  

This year’s 4/20 performance reaffirms the cannabis holiday’s staying power — and offers a strong signal of the industry’s growing retail sophistication and consumer loyalty.

🌿 Global Celebrations and Advocacy

• Melbourne, Australia: Over a hundred cannabis legalization supporters gathered peacefully at Flagstaff Gardens to celebrate "420 Day." Organized by the Legalise Cannabis party, the event featured picnicking, speeches, and campaign material distribution, emphasizing the push for legalizing and regulating recreational cannabis similar to alcohol and tobacco.

🎶 U.S. Festivals and Events

• Charlotte, North Carolina: The "Up The Smoke" festival, featuring artists like Kodak Black and DaBaby, highlighted growing support for cannabis legalization amidst state bills like HB 563 and HB 1011 aiming to legalize medical cannabis.

• Atlanta, Georgia: The SweetWater 420 Fest celebrated its 20th anniversary with performances by Cypress Hill, The Revivalists, and others, offering a cannabis-friendly atmosphere with interactive activities.

• New York City: Events like Happy Munkey's celebration in Brooklyn and gatherings in Washington Square Park and Union Square provided live DJ sets, cannabis activations, and community engagement, reflecting the city's vibrant cannabis culture.

🛍️ Retail Milestones

• Rochester, New York: Good Life Collective, the city's first licensed cannabis dispensary, experienced a surge in business during the 4/20 celebrations, with edibles and drinkables being particularly popular among customers.

📈 Industry Insights

• Consumer Trends: A recent poll indicated that three in four marijuana consumers appreciate 4/20 promotions from non-cannabis brands, viewing them as a sign of the industry's mainstream acceptance.

Much of the content on this site is geared towards established cannabis professionals, offering insights and updates for those already well-versed in the industry. However, we've noticed a growing number of cannabis-curious visitors—people who are interested in exploring a career in cannabis but aren't sure where to start. This guide is designed to help those newcomers understand the role of a budtender, a common entry point into the industry, and explore the opportunities that lie beyond.

The Role of a Budtender

Budtenders are at the heart of the dispensary experience—they guide customers, provide product knowledge, and ensure compliance. They serve as the face of the dispensary, often being the first point of contact for customers and those responsible for shaping a positive experience. If you're eyeing a career as a budtender or thinking of transitioning from another cannabis role, here are some tips to help you get started and grow.

Becoming a Budtender

To become a budtender, you don’t need to be a cannabis expert, but a passion for learning and strong customer service skills are essential. Start by understanding the responsibilities of guiding customers, managing inventory, handling sales, and always staying compliant with cannabis laws. Budtenders need to be well-versed in the different strains, products, and consumption methods to provide the best possible recommendations to customers. Dispensaries value team players who are curious about the industry, empathetic towards customers, and have a knack for building relationships. A strong application highlighting your cannabis knowledge, enthusiasm, and customer service background can make you stand out in a competitive job market.

Growth Opportunities Beyond Budtending

Budtending is often a stepping stone in the cannabis world. Many budtenders move up to roles in management, product procurement, or even brand ambassador positions. It’s a role that offers a front-row seat to learn about different aspects of the cannabis business, from retail operations to customer preferences. If you want to grow beyond budtending, focus on deepening your product knowledge, understanding the business side of dispensary operations, and showing leadership skills in your role. Taking the initiative to learn more about inventory management, sales strategies, and compliance will set you apart. Networking with colleagues, attending industry events, and staying updated on industry trends can also open doors to more advanced opportunities in cannabis retail or other segments of the industry.

Exploring Career Paths in Cannabis

Growth opportunities in the cannabis industry are abundant for those willing to put in the work. Beyond budtending, you can explore roles in inventory management, compliance, marketing, or even cultivation. Budtenders who demonstrate a deep understanding of cannabis products and exceptional customer service skills often transition into training roles, helping onboard and educate new hires. Others may move into purchasing roles, selecting the best products for their dispensaries, or even into advocacy roles, working to promote cannabis education and reform. The skills you gain as a budtender—like customer communication, product knowledge, and compliance awareness—are transferable and can help you move up the ladder within the cannabis industry.

Conclusion

Whether you're just starting or looking to grow, budtending offers valuable experience and insight into the booming cannabis sector. Approach the role with dedication, and you’ll gain not only a deep understanding of cannabis products and the industry but also the skills and connections that can propel your career forward. The cannabis industry is evolving rapidly, and budtenders are in a unique position to be part of that growth, with plenty of opportunities to expand their roles and make an impact.

To-Do List for Aspiring Budtenders

• Learn About Cannabis Products: Understand different strains, consumption methods, and the effects of various products.

• Develop Customer Service Skills: Empathy and the ability to connect with customers are crucial for success.

• Research State Regulations: Be knowledgeable about the compliance and legal requirements in your area.

• Craft a Strong Resume: Highlight your passion for cannabis, customer service experience, and eagerness to learn.

• Network in the Industry: Attend events, join online cannabis communities, and connect with others in the field.

• Stay Updated on Industry Trends: Keep learning about new products, regulations, and changes in the cannabis landscape.

• Get Certified: Consider some cannabis certification.

Since the legalization of adult-use cannabis in New York in 2021, the state's cannabis market has seen significant growth in retail sales, job creation, and social equity initiatives. As dispensaries expand, opportunities abound for those in the industry—despite challenges like the ongoing fight against the illicit market. For a deeper dive into the progress and future of cannabis in New York, check out the Marihuana Regulation and Taxation Act (MRTA) Implementation Report. Successes in New York’s Dispensary Landscape

One of the biggest achievements in New York’s cannabis industry has been the establishment of a robust and regulated market. The state’s Office of Cannabis Management (OCM) and the Cannabis Control Board (CCB) have been at the forefront, issuing adult-use licenses, which directly support new business creation and job opportunities across the state. From January 2023 to mid-September 2024, retail sales in New York surged to nearly $500 million. This growth trajectory reflects both rising consumer demand and the expanding number of dispensaries serving the market.

From the MRTA Implementation Report

Another key success is the Conditional Adult-Use Retail Dispensary (CAURD) license program. Aimed at fostering social equity, CAURD licenses have given entrepreneurs from communities disproportionately impacted by cannabis prohibition a leg up in the market. This initiative underscores New York’s commitment to integrating social justice into the cannabis business.

Additionally, the revenue growth is notable. The regulated market has generated millions in tax revenue that will go towards state education, community reinvestment, and public health initiatives. With state-wide retail sales reaching $97.4 million in August 2024 alone, the dispensary landscape is undoubtedly a cornerstone of New York’s cannabis economy.

Headwinds Facing New York Cannabis Dispensaries

Despite these successes, the road to prosperity for dispensaries in New York has not been without its challenges. A significant headwind has been the ongoing struggle to curb the illicit market. Unlicensed sellers continue to siphon potential customers from the legal dispensaries, undermining the profits and credibility of the licensed market. Enforcement efforts are increasing, and the state has established a Cannabis Enforcement Task Force to shut down illegal operators, but the presence of these unregulated sellers remains a significant issue.

Compliance with evolving regulations is another obstacle dispensaries must navigate. The regulatory burden is high, from product labeling and advertising restrictions to stringent safety testing. While these measures are designed to protect consumers and ensure product quality, they can be costly for businesses trying to stay afloat, particularly for smaller operators or those entering the market through social equity programs.

The Vital Role of Registered Organizations in New York’s Cannabis Market Expansion

Registered Organizations (ROs) play a crucial role in New York's cannabis ecosystem by operating both medical and adult-use dispensaries. As of September 15, 2024, 24 medical dispensaries and 10 dual-use dispensaries are run by ROs, providing regulated cannabis products to both medical patients and adult-use consumers. This integration of services allows for streamlined access across the state, contributing to New York’s growing cannabis market, which has generated $653.9 million in adult-use retail sales by September 2024. With 1,342 adult-use licenses issued and another 362 provisionally approved, the dispensary landscape continues to expand, strengthening the state’s cannabis infrastructure.

Opportunities for Growth and Expansion

Looking ahead, New York’s dispensary landscape holds immense potential, especially as more retail locations open across the state. The Cannabis Growers Showcase, a temporary initiative that allowed licensed cannabis growers and processors to showcase their products at market-style events, demonstrated that consumer interest is strong when access to products is expanded beyond traditional dispensaries​. Expanding such opportunities could be a boon for dispensaries in underserved areas.

Additionally, New York’s focus on social and economic equity remains a critical opportunity for aspiring dispensary owners. The state is actively promoting reduced licensing fees and providing technical assistance to applicants from marginalized communities, ensuring that the cannabis industry remains accessible to a diverse group of entrepreneurs.

Moreover, with the state’s efforts to strengthen its agricultural sector by supporting cannabis growers, dispensaries could forge stronger connections with local cultivators. This could create a more localized, sustainable supply chain, benefiting both the dispensaries and the New York economy.

Key Takeaways for Cannabis Dispensaries in New York

New York’s cannabis dispensary sector has already achieved significant milestones in a short time, demonstrating the potential for both economic growth and social change. While headwinds such as the illicit market and regulatory hurdles present challenges, the opportunities for growth are substantial. For cannabis professionals working in dispensaries or hoping to enter the field, now is the time to leverage these opportunities, whether through direct engagement with state programs or by capitalizing on the expanding consumer base. With New York continuing to lead with a progressive framework, the future looks bright for dispensaries that can navigate the challenges and seize the opportunities ahead.

10 Key Stats on Cannabis Growth in New York

1. $500 million in cannabis retail sales from January 2023 to mid-September 2024.

2. $97.4 million in sales during August 2024, the highest monthly total.

3. Over 1,300 licenses were issued as of September 2024 across cultivation, retail, and distribution.

4. 50% of adult-use licenses are allocated to social and economic equity applicants.

5. Over 40% of cannabis tax revenue is directed to education and community programs.

6. More than 8,500 new jobs have been created across the cannabis sector.

7. $162.88 million in Q2 2024 retail sales, compared to $23.08 million in Q2 2023.

8. $5 million in CAURD grant funding for social equity dispensaries.

9. 20 CAURD locations opened by September 2024 under the Social Equity Investment Fund.

10. 50% increase in legal sales due to enforcement against illicit operations.

The Department of Justice's recent proposal to reschedule marijuana from a Schedule I to a Schedule III substance under the Controlled Substances Act could have significant implications for the cannabis industry. While it stops short of full decriminalization, this change could benefit cannabis retailers and their employees in several important ways.

Reduced Tax Burdens for Dispensaries

According to Adam Hoffer and Benjamin Patrick, authors from the nonprofit Tax Foundation, rescheduling marijuana would bring needed tax relief to cannabis businesses. The Tax Foundation, known for its focus on sound tax policy, highlights that marijuana's current classification as a Schedule I substance places it under Section 280E of the Internal Revenue Code, which prevents cannabis businesses from deducting normal operating expenses like wages, rent, and utilities.

As Hoffer and Patrick explain in their article, "Rescheduling marijuana would alleviate these disproportionate tax burdens by removing marijuana businesses from the jurisdiction of Section 280E of the IRC." This change would significantly reduce operating costs and make cannabis businesses more competitive, bringing their tax treatment in line with other industries.

It is important to note that this rescheduling is still a proposal and not yet finalized. The Federal Register states, "On May 21, 2024, the Department of Health and Human Services provided its recommendation to reschedule marijuana," but final implementation depends on further regulatory evaluations.

Increased Profitability and Business Growth

With the ability to deduct operating expenses, dispensaries are likely to see increased profitability. Hoffer and Patrick point out that, under current regulations, some cannabis businesses face effective tax rates as high as 116%, making it difficult to sustain operations. Rescheduling marijuana would allow businesses to retain more earnings, reinvest into growth initiatives, and improve customer experiences.

This financial health could encourage dispensaries to expand, enhance offerings, and invest in new technologies. It would also create a more competitive marketplace, enabling small and mid-sized businesses to enter the industry without being hindered by high tax obligations.

Positive Impact on Employee Salaries and Benefits

The reduced tax burden would directly impact employees working in dispensaries. Increased profitability could allow dispensaries to raise salaries, offer bonuses, and provide comprehensive employee benefits like health insurance and retirement plans. This could help retain talent and make the cannabis industry more attractive to potential employees.

Boost for Industry Stability and Innovation

Rescheduling marijuana would help stabilize the industry. Hoffer and Patrick note, "Granting cannabis businesses a more neutral status in the federal tax code will stabilize the industry, thereby stabilizing the federal and state tax revenues derived from it." Stability in the industry would lead to more investments in research, new products, and advanced retail technologies.

A more level playing field would also foster competition, driving dispensaries to innovate in areas such as customer loyalty programs, retail experiences, and sustainability initiatives.

A New Era for Cannabis Retail

The proposed move to reschedule marijuana represents a potential turning point for cannabis retail. The elimination of Section 280E constraints would allow dispensaries to become more competitive, invest in employee wellbeing, and grow their businesses. As Hoffer and Patrick conclude in their article for the Tax Foundation, "The tax treatment of marijuana no longer captured by Section 280E would better reflect the principles of sound taxation, simplifying the tax code and allowing for better stability of revenue."

This change promises a brighter future for cannabis retailers and their employees, from increased profitability and market expansion to enhanced employee compensation. Cannabis businesses will finally have a fair shot at thriving, benefiting both the industry and the professionals who keep it running every day.

For more details, you can read the full article by Adam Hoffer and Benjamin Patrick at the Tax Foundation: Rescheduling Marijuana: Tax Consequences.

The Fresh Toast, a lifestyle and cannabis, predicted back in August 2020 that cannabis industry workers would overtake computer programmers. If you bet with them, well, you one. According to The Fresh Toast, there are 440,000 people with cannabis jobs, and only 343,000 in computer programming.

Cannabis Workers Now Outnumber These Industries

The Fresh Toast - We predicted it, cannabis workers now outnumber these industries. We have the facts and figures.

thefreshtoast.com/cannabusiness/cannabis-workers-now-outnumber-these-industries

In the article, The Fresh Toast points out that “the average salary of programmer is $100K while in the cannabis industry, it is $47K.”

With cannabis destigmatization, more states embracing adult use, and the smell of Federal changes in the air, there’s no doubt the number of cannabis jobs will keep growing. Will we hit the 4,717,192 who are currently working in fast food over the next two years? Maybe not, but cannabis jobs could overtake the 1.5 million REALTORS (members of the National Association of Realtors), plus the benefits are a lot better.